Trellus Management Company’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,000
| Closed | -$2.26M | – | 67 |
|
|
2022
Q3 | $2.26M | Hold |
10,000
| – | – | 2.74% | 5 |
|
|
2022
Q2 | $1.89M | Hold |
10,000
| – | – | 2.3% | 6 |
|
|
2022
Q1 | $2.49M | Buy |
10,000
+451
| +5% | +$112K | 1.45% | 7 |
|
|
2021
Q4 | $1.49M | Buy |
9,549
+1,413
| +17% | +$220K | 0.99% | 14 |
|
|
2021
Q3 | $1.63M | Hold |
8,136
| – | – | 1.19% | 16 |
|
|
2021
Q2 | $2.08M | Buy |
8,136
+603
| +8% | +$154K | 1.44% | 12 |
|
|
2021
Q1 | $2M | Buy |
7,533
+653
| +9% | +$173K | 1.04% | 16 |
|
|
2020
Q4 | $2.54M | Buy |
6,880
+213
| +3% | +$78.5K | 2.09% | 7 |
|
|
2020
Q3 | $1.63M | Buy |
6,667
+707
| +12% | +$173K | 1.67% | 12 |
|
|
2020
Q2 | $1.72M | Buy |
5,960
+767
| +15% | +$221K | 1.86% | 9 |
|
|
2020
Q1 | $1.06M | Buy |
5,193
+3,065
| +144% | +$625K | 1.9% | 14 |
|
|
2019
Q4 | $951K | Sell |
2,128
-705
| -25% | -$315K | 1.59% | 17 |
|
|
2019
Q3 | $871K | Buy |
2,833
+530
| +23% | +$163K | 0.87% | 19 |
|
|
2019
Q2 | $732K | Buy |
+2,303
| New | +$732K | 0.99% | 27 |
|